Letter to the Editor

Eur Rev Med Pharmacol Sci 2018; 22 (15): 4755-4756
DOI: 10.26355/eurrev_201808_15606

Pilonidal disease, hidradenitis suppurativa and follicular occlusion syndrome: a diagnostic challenge

A. Pesce, G. Capuzzo, B. Cammisuli, M.L. Musumeci, G. Micali
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (14): 4401-4402
DOI: 10.26355/eurrev_201807_15489

Comment on: MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma

P.C. Pafundi, A. Caturano, G. Franci
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (11): 3275-3276
DOI: 10.26355/eurrev_201806_15145

Comment on “The influence of palatable high-energy diet in diet-induced obesity pregnant rats on offspring oxidative stress in liver”

V. Brunelli, P. Perillo, S. Milione
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (10): 2917-2917
DOI: 10.26355/eurrev_201805_15044

A question on Helicobacter pylori prevalence in obese Turkish patients

R. Pellicano, M. Durazzo
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (10): 2915-2916
DOI: 10.26355/eurrev_201805_15043

Advance healthcare directives: moving towards a universally recognized right

G. Montanari Vergallo, F.P. Busardò, P. Berretta, E. Marinelli, S. Zaami
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (8): 2189-2190
DOI: 10.26355/eurrev_201804_14801

Cardiac magnetic resonance in systemic sclerosis patients with cardiac symptoms: do we really need it?

G. De Luca, C. Campochiaro, G. Cavalli, L. Dagna
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (8): 2187-2188
DOI: 10.26355/eurrev_201804_14799

Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men

G. Pontillo, D. Macaro, L. Monaco
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (7): 1877-1878
DOI: 10.26355/eurrev_201804_14707

Comment on “Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc”

G. Parisi, T. Ceschia, M. Trovò
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (7): 1875-1876
DOI: 10.26355/eurrev_201804_14706

Estramustine phosphate induces prostate cancer cell line PC3 apoptosis by down-regulating miR-31 levels

C. D’Aniello, S. Pisconti, S. Facchini, C. Imbimbo, C. Cavaliere
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (7): 1873-1874
DOI: 10.26355/eurrev_201804_14705

Use of alpha-lactalbumin for the management of PCOS in inositols resistant women

V. Unfer
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (6): 1530-1532
DOI: 10.26355/eurrev_201803_14556

Comment about “The hyperthermic intraoperative intraperitoneal chemotherapy in the treatment of advanced abdominopelvic cancer. Personal experience on 103 procedures during a seventeen year period in a single Italian center”

R. Fisichella, A. Cappellani, S. Berretta
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (6): 1528-1529
DOI: 10.26355/eurrev_201803_14555

Comment on “The effect and mechanism of metallothionein MT1M on hepatocellular carcinoma cell”

S. Milione, D. Mastrocinque, C. Acierno
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (6): 1525-1527
DOI: 10.26355/eurrev_201803_14554

LncRNA colon cancer-associated transcript 1 (CCAT1) in ovarian cancer

P. Coni, A. Madeddu, L. Kuqi, G. Pichiri, A. Occhinegro, D. Ratto, G. Orrù
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (6): 1521-1524
DOI: 10.26355/eurrev_201803_14553

MiRNA-155 and colorectal cancer, the role of real time PCR in laboratory diagnosis

G. Orrù, A. Occhinegro, D. Ratto, V. Cesaroni, P. Rossi
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (5): 1178-1179
DOI: 10.26355/eurrev_201803_14455

Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells. Point of view from pharmacogenetics field

G. Marotta, T. Muto, G. Benincasa, A. De Monaco
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (5): 1175-1177
DOI: 10.26355/eurrev_201803_14454

Comment on: “Formyl peptide receptor 2 mediated chemo-therapeutics drug resistance in colon cancer cells”

F. Condorelli
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (5): 1171-1174
DOI: 10.26355/eurrev_201803_14453

MicroRNA-552 in colorectal cancer with poor prognosis. Its role as a novel molecular biomarker

A. Scano, D. Ratto, A. Occhinegro, A. Pedroncelli, P. Rossi
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (5): 1169-1170
DOI: 10.26355/eurrev_201803_14452

Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma

C. D’Aniello, S. Pisconti, S. Facchini, C. Imbimbo, C. Cavaliere
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (4): 863-865
DOI: 10.26355/eurrev_201802_14363

The challenge of clinical application of FM2 cannabis oil produced in Italy for the treatment of neuropathic pain

S. Pichini, R. Pacifici, F.P. Busardò, A. Tagliabracci, R. Giorgetti
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (4): 860-862
DOI: 10.26355/eurrev_201802_14362

Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients

R. Fisichella, S. Berretta
Free PDF Download